top
Search terms
Results 1 - 8 of 8 - ordered by :
Epeuropace

Abstract The aim of this study was to evaluate the rate of bleeding, thromboembolic complications, and the rate of stent thrombosis or restenosis in patients with atrial fibrillation (AF) undergoing ...

Europace, Short Communication, Philipp Halbfass, Sabine Janko, Uwe Dorwarth, Gotthard Riess, Diethmar Antoni, Ellen Hoffmann

Date : 01/07/2009 Item size : 151680 bytes
Ehjournal

Currently, the optimal combination of anticoagulants and anti-platelet therapy is unknown, but it is well established that the combination of regular doses and regimens as prescribed in AF or after ...

European Heart Journal, Moser, Martin, Olivier, Christoph B., Bode, Christoph

Date : 21/01/2014 Item size : 382265 bytes
Ehjournal

Currently, the optimal combination of anticoagulants and anti-platelet therapy is unknown, but it is well established that the combination of regular doses and regimens as prescribed in AF or after ...

European Heart Journal, Moser, Martin, Olivier, Christoph B., Bode, Christoph

Date : 21/01/2014
Ehjournal

Introduction Drug-eluting stents (DES) are a great advance in interventional cardiology because of their significant reduction of restenosis in relation to conventional bare-metal stents (BMS). DES ...

European Heart Journal, Ruiz-Nodar, Juan M., Marín, Francisco, Sánchez-Payá, José, Hurtado, José A., Valencia-Martín, José, Manzano-Fernández, Sergio, Roldán, Vanessa, ...

Date : 01/04/2009 Item size : 315821 bytes
ESC365

Dual versus single antiplatelet therapy in combination with antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: a meta-an

Date : 27/08/2018
ESC365

Dual versus single antiplatelet therapy in combination with antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: a meta-an

Date : 27/08/2018
Revistaespanola

Introduction Based on the current European guidelines,1, 2 stratification for thromboembolic risk in atrial fibrillation (AF) is largely based on clinical risk scoring systems, such as the CHADS2 ...

Revista Española de Cardiología

Date : 01/01/2013 Item size : 67834 bytes
Revistaespanola

To the Editor, Triple antithrombotic therapy with aspirin, clopidogrel, and warfarin is used in about 5% of patients after coronary stent implantation, mostly due to atrial fibrillation and left ...

Revista Española de Cardiología

Date : 01/03/2014 Item size : 35435 bytes